Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02616 CSTONE PHARMA-B
RT Nominal down6.165 -0.010 (-0.162%)
Latest  |  Final  |  Interim
Non-current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others73,439-4.683%77,04793,218105,664138,379
Land & other Lease Assets16,525171.748%6,08137,32547,70468,187
Intangible Assets143,847-3.901%149,687161,366173,045159,699
Interests in Asso. & JCEs0--0000
Other Non-current Assets14,53517.550%12,36511,6495,79925,245

248,3461.291%245,180303,558332,212391,510
Current Assets
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Inventories74,174-36.542%116,886286,096108,82822,188
Trade Receivables107,358217.524%33,81183,929172,43877,133
Cash & Bank Balances1,395,24885.120%753,699387,937996,671558,684
Other Current Assets230,86910.574%208,792331,94651,850588,912
Assets Held for Sale0--0000

1,807,64962.385%1,113,1881,089,9081,329,7871,246,917
Current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Trade Payables99,03528.282%77,201338,029315,106290,414
S-T Debt & Leases167,622-12.509%191,58893,216139,31344,918
Other Current Liabilities237,965-1.437%241,434250,761395,919611,150
Liab asso w/ Assets Held for Sale0--0000

504,622-1.098%510,223682,006850,338946,482
Net Current Assets1,303,027116.103%602,965407,902479,449300,435
Total Assets Less Current Liabilities1,551,37382.914%848,145711,460811,661691,945
Non-current Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
L-T Debt & Leases189,61620.829%156,929262,757224,135241,372
Other Non-current Liabilities69,254-6.975%74,44784,832130,6961,247

258,87011.883%231,376347,589354,831242,619
Capital and Reserves
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
  Share Capital1,0848.617%998860860802
  Reserves1,291,419109.724%615,771363,011455,970448,524
  Others0--0000
Shareholders' Funds1,292,503109.560%616,769363,871456,830449,326
Non-controlling Interests0--0000
Others0--0000

1,292,503109.560%616,769363,871456,830449,326
Commitments and Contingent Liabilities
2026/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2025/12
RMB(K¥)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
Commitments------000
Contingent Liabilities------000
Remarks:  Real time quote last updated: 09/09/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -252,284
%Change-6.625%
EPS / (LPS)RMB -0.170
NBV Per Share (¥)RMB 0.807
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.